Safety and tolerability of MRI-guided infusion of AAV2-hAADC into the mid-brain of nonhuman primate

@article{Sebastian2014SafetyAT,
  title={Safety and tolerability of MRI-guided infusion of AAV2-hAADC into the mid-brain of nonhuman primate},
  author={Waldy San Sebastian and A. Kells and J. Bringas and L. Samaranch and P. Hadaczek and A. Ciesielska and M. Macayan and P. Pivirotto and J. Forsayeth and Sheryl Osborne and J. F. Wright and F. Green and G. Heller and K. Bankiewicz},
  journal={Molecular Therapy. Methods & Clinical Development},
  year={2014},
  volume={3}
}
  • Waldy San Sebastian, A. Kells, +11 authors K. Bankiewicz
  • Published 2014
  • Medicine
  • Molecular Therapy. Methods & Clinical Development
  • Aromatic L-amino acid decarboxylase (AADC) deficiency is a rare, autosomal-recessive neurological disorder caused by mutations in the DDC gene that leads to an inability to synthesize catecholamines and serotonin. As a result, patients suffer compromised development, particularly in motor function. A recent gene replacement clinical trial explored putaminal delivery of recombinant adeno-associated virus serotype 2 vector encoding human AADC (AAV2-hAADC) in AADC-deficient children. Unfortunately… CONTINUE READING
    18 Citations
    Widespread AAV1- and AAV2-mediated transgene expression in the nonhuman primate brain: implications for Huntington’s disease
    • 25
    Axonal transport of AAV9 in nonhuman primate brain
    • 20
    AAV viral vector delivery to the brain by shape-conforming MR-guided infusions.
    • 21
    Kinetics and MR-Based Monitoring of AAV9 Vector Delivery into Cerebrospinal Fluid of Nonhuman Primates
    • 10
    Extensive Transduction and Enhanced Spread of a Modified AAV2 Capsid in the Non-human Primate CNS.
    • 18

    References

    SHOWING 1-10 OF 35 REFERENCES
    Long-term clinical improvement in MPTP-lesioned primates after gene therapy with AAV-hAADC.
    • 248
    A dose-ranging study of AAV-hAADC therapy in Parkinsonian monkeys.
    • 87
    Eight years of clinical improvement in MPTP-lesioned primates after gene therapy with AAV2-hAADC.
    • 123
    Biodistribution of adeno-associated virus type-2 in nonhuman primates after convection-enhanced delivery to brain.
    • 55
    A Phase I Study of Aromatic L-Amino Acid Decarboxylase Gene Therapy for Parkinson's Disease.
    • 177